Email this page: News Release

Phase 3 Clinical Study of RELISTOR Presented at American Pain Society Meeting Showed Positive Activity for the Treatment of Opioid-Induced Constipation in Chronic,Non-Cancer Pain Patients

To (email address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:   Copy yourself These email addresses will be used to email the page on your behalf and will not be used by Progenics Pharmaceuticals, Inc. for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Progenics Pharmaceuticals, Inc. prevent automated submissions.